OHNO TSUNEYA has a total of 26 patent applications. Its first patent ever was published in 1993. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are BIOALLIANCE PHARMA, ONYVAX LTD and O'HAGAN DEREK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 5 | |
#3 | Canada | 5 | |
#4 | WIPO (World Intellectual Property Organization) | 5 | |
#5 | EPO (European Patent Office) | 4 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Measuring microorganism processes | |
#5 | Analysing materials | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Ohno Tsuneya | 26 |
#2 | Matsuhisa Akio | 7 |
#3 | Uehara Hirotsugu | 5 |
#4 | Kufe Donald W | 5 |
#5 | Eda Soji | 5 |
#6 | Keshi Hiroyuki | 3 |
#7 | Hirotsu Takuo | 2 |
#8 | Yamamoto Seiji | 1 |
#9 | Weichselbaum Ralph R | 1 |
#10 | Iwami Takahisa | 1 |
Publication | Filing date | Title |
---|---|---|
WO2009025094A1 | Method of diagnosing cancer in mammal | |
EP1732591A2 | Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer | |
AU2003301023A1 | Preparation and administration of hybrid cell vaccines for the prevention of cancer | |
US2007059687A1 | Process for evaluating phagocytotic function and use thereof | |
AU2002225990B2 | Fusion cells and cytokine compositions for treatment of disease | |
CA2192813A1 | Methods of inducing gene expression by ionizing radiation |